Patients with CS development had a lower mean level of total protein and a higher mean level of albumin compared to patients without CS (59.4 vs. 69.6 g/l, p = 0.004, and 32.0 vs. 26.1 g/l, p = 0.02, respectively). This evidence concerns the gene ALB and Cowden syndrome 1.